openPR Logo
Press release

PANATecs GmbH in new facilities in Heilbronn

02-14-2013 02:49 PM CET | Science & Education

Press release from: PANATecs GmbH


PANATecs is moving into modern, custom-built facilities in Heilbronn

PANATecs GmbH relocated its headquarters late last year from Tübingen to Heilbronn, where housing firm Stadtsiedlung Heilbronn constructed modern laboratory facilities at the Wohlgelegen research park in accordance with PANATecs’ specifications and GMP standards.

At the time of the move, PANATecs also expanded its portfolio to include CEF pools for immunological purposes - available up to now among others - and the P-CHECK® kit for testing raw materials. The various kit systems and peptide-based research and control reagents are used in the fields of immunology, protein chemistry and protein analysis, among other applications.
PANATecs does its development work in keeping with ISO and GMP quality standards, which, combined with the company’s expertise in mass-spectrometry-based analytical methods, guarantees mass-produced products of the highest quality.

All of these products and reagents are now available and can be purchased at the company’s webshop at
The quality of PANATecs’ mass-spectroscopy-based services remains as high as ever.

PANATecs GmbH specializes in providing mass-spectrometry-based services for the pharmaceutical and biotech industries, and in manufacturing and selling bioanalytical substances (such as peptides, antibodies, marker reagents, etc.) for research purposes.
The company is ISO 9001 certified and is an authorized GMP manufacturer for test laboratories as defined in the German Medicinal Products Act.

Inselwiesenstraße 10
74076 Heilbronn

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release PANATecs GmbH in new facilities in Heilbronn here

News-ID: 252015 • Views:

More Releases from PANATecs GmbH

PANATecs has formed a strategic alliance with HWI ANALYTIK GmbH
PANATecs has formed a strategic alliance with HWI ANALYTIK GmbH
May 13, 2013 Since the start of this year, PANATecs GmbH has had a strategic alliance with HWI ANALYTIK GmbH, headquartered in Rülzheim. PANATecs GmbH is pleased to have HWI ANALYTIK GmbH as a cooperation partner with a complementary portfolio for the field of classical pharmaceutical products with chemically defined and botanical active substances. HWI ANALYTIK GmbH was founded in 1991 and offers a large product portfolio of pharmaceutical services with its
Spring rebate on EdU cell proliferation kits
Spring rebate on EdU cell proliferation kits
February 28, 2013 30% spring rebate on EdU cell proliferation kits Offer ends March 31, 2013! PANATecs GmbH is once again expanding its life-science tools portfolio, placing an emphasis on mass-spectroscopy services for biopharmaceutical applications. After entering into a distribution partnership with BASF subsidiary Baseclick in December 2012, PANATecs GmbH now offers patented click chemistry products. Available beginning immediately, these molecular and cell biology detection tools deliver high yields and considerable sensitivity.
PANATecs has been nominated for the 2011 CPhI Innovation Award
PANATecs has been nominated for the 2011 CPhI Innovation Award
06.10.2011 During the CPhI Fair from 25-27 October 2011 in Frankfurt, PANATecs was nominated for the 2011 CPhI Innovation Award The application for the 2011 CPhI Innovation Award 2011 was based on the P-CHECK® technology, which exploits the FRET phenomenon (Fluorescence Resonance Energy Transfer) and is used to demonstrate protease contamination in various areas. P-CHECK® technology is primarily used to detect protease contamination in protein-based raw materials used in diagnostic testing,

All 4 Releases

More Releases for Heilbronn

m + mv invests in High-Tech Gruenderfonds III
media + more venture Beteiligungs GmbH & Co. KG, a company comprising three regional publishers in Mainz, Freiburg and Heilbronn, is investing EUR 2.5 million in High-Tech Gründerfonds III (HTGF III). The consortium of three publishers is thus once again reinforcing its commitment to and investments in innovative technologies from Germany for the publishing industry. HTGF III invests venture capital in young, high potential high-tech start-ups that can turn promising research
New customer for WOLFFKRAN in Frankfurt - FABER & SCHNEPP buys its first WOLFF
Frankfurt – August 2011. The municipal fire department of Frankfurt is expanding its facilities with a new training center situated adjacent to the current training and administration building. The construction work is scheduled to be completed by fall 2012. In order to realize this project, the mid-sized construction company FABER & SCHNEPP Hoch- und Tiefbau GmbH & Co. KG in Gießen, which received the contract for carrying
Novalung and Medos start cooperation
Due to the acquisition of Medos Medizintechnik AG by the private equity fund Zukunftsfonds Heilbronn (“Future Fund of Heilbronn”) the company will cooperate closely in the future with Novalung GmbH, which is expected to strengthen both medical device companies. The Zukunftsfonds Heilbronn (zfhn) announced that it has acquired Medos Medizintechnik AG from Ventizz Capital Partners Advisory AG. The purchase agreement was signed on January 7, 2011. With this
Novalung now in “Future Park”
The innovative medical device company moves into new headquarters in Southern Germany On October 27th the new head office of Novalung GmbH was officially opened. During a short celebration CEO Dr. Georg Matheis and COO Hannes Wetscher inaugurated the new offices located in the newly constructed technology park “Zukunftspark” (Future Park) in Heilbronn, approximately halfway between Stuttgart and Frankfurt in the South of Germany. ”Our innovative solutions for lung failure are gaining
Novalung records 50% growth
The innovative therapies for lung failure from medical device company Novalung GmbH continue to gain acceptance. Additional financing will allow the Talheim (Germany) based company to accelerate the development of new products. Novalung GmbH increased sales by 50% in 2009. The positive trend continues through the first months of 2010. The increasing acceptance of the company’s innovative therapies for lung failure both in Germany and abroad is driving continuing growth. Manufacturing
greenovation launches Bryo-Speed™ and Bryo-Master™ for the production of the …
From pilot study to stable production: in Bryo-Speed™ and Bryo-Master™ greenovation presents a production platform for custom-made pharmaceuticals – Presentation of the new products at BioProduction 2007 in Berlin Heilbronn/ Germany – November 1st 2007 – Bryo-Speed™ and Bryo-Master™ are greenovation’s innovative production systems for the effective optimization and creation of pharmaceutically highly efficient glycoproteins: The production platform is based on bryotechnology which has been developed by greenovation